244 related articles for article (PubMed ID: 17347989)
1. A new variant database for mismatch repair genes associated with Lynch syndrome.
Woods MO; Williams P; Careen A; Edwards L; Bartlett S; McLaughlin JR; Younghusband HB
Hum Mutat; 2007 Jul; 28(7):669-73. PubMed ID: 17347989
[TBL] [Abstract][Full Text] [Related]
2. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
Stoffel EM
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
[TBL] [Abstract][Full Text] [Related]
3. A database to support the interpretation of human mismatch repair gene variants.
Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
Bellizzi AM; Frankel WL
Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131
[TBL] [Abstract][Full Text] [Related]
5. [Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].
Nilbert M; Grönberg H; Lindblom A
Lakartidningen; 2002 Aug; 99(34):3296-300. PubMed ID: 12362848
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
7. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Vasen HF
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
[TBL] [Abstract][Full Text] [Related]
8. The genetics of HNPCC: application to diagnosis and screening.
Abdel-Rahman WM; Mecklin JP; Peltomäki P
Crit Rev Oncol Hematol; 2006 Jun; 58(3):208-20. PubMed ID: 16434208
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
10. The frequency of Muir-Torre syndrome among Lynch syndrome families.
South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
[TBL] [Abstract][Full Text] [Related]
11. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes.
Ou J; Niessen RC; Lützen A; Sijmons RH; Kleibeuker JH; de Wind N; Rasmussen LJ; Hofstra RM
Hum Mutat; 2007 Nov; 28(11):1047-54. PubMed ID: 17594722
[TBL] [Abstract][Full Text] [Related]
13. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
[TBL] [Abstract][Full Text] [Related]
14. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome in colorectal cancer patients.
Giráldez MD; Castellví-Bel S; Balaguer F; Gonzalo V; Ocaña T; Castells A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):573-83. PubMed ID: 18402524
[TBL] [Abstract][Full Text] [Related]
17. High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.
Chong G; Jarry J; Marcus V; Thiffault I; Winocour S; Monczak Y; Drouin R; Latreille J; Australie K; Bapat B; Gordon PH; Giguère Y; Gologan A; Galiatsatos P; Jass JR; Wong N; Zaor S; Palma L; Kasprzak L; Tischkowitz M; Foulkes WD
Hum Mutat; 2009 Aug; 30(8):E797-812. PubMed ID: 19459153
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome: a pediatric perspective.
Huang SC; Durno CA; Erdman SH
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):144-52. PubMed ID: 24051481
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
